Search for: "Bristol-Meyers Squibb Co"
Results 1 - 20
of 42
Sort by Relevance
|
Sort by Date
19 Feb 2024, 1:43 pm
” Bristol-Myers Squibb Co. v. [read post]
20 Dec 2023, 5:00 am
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
27 Nov 2022, 8:10 pm
.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
17 Nov 2022, 2:15 pm
Bristol-Meyers Squibb Co., 156 N.J. 455 (1998). [read post]
20 Mar 2021, 8:45 pm
Brian Brookey of Tucker Ellis LLP; Serena Farquharson-Torres of Bristol-Meyers Squibb; Gloria Fuentes of Merck & Co. [read post]
15 Dec 2020, 5:00 am
Supreme Court opinions, the most recent of which was in the case of Bristol-Myers Squibb v. [read post]
9 Dec 2020, 12:02 pm
This theory sounds rather odd, though it has some support in previous cases: World-Wide Volkswagen seemed to think the manufacturers might be liable wherever Audis were sold, and Bristol-Meyers Squibb made sure to note that the plaintiffs "did not ingest Plavix in California," as if that fact should have mattered. [read post]
4 Apr 2020, 8:25 pm
Karen Cochran of Shell Oil Co., Henry Hadad of Bristol-Meyers Squibb Co., Mike Ray of Sterne Kessler Goldstein Fox, and Todd Walters of Buchanan Ingersoll & Rooney PC will address the following questions concerning the management of a corporate IP department or IP practice during a crisis: • How can the you continue supporting clients' innovation when significant numbers of employees are teleworking and many are without childcare? [read post]
31 Mar 2020, 1:27 pm
In so holding, the court determined that the Supreme Court’s ruling in a mass tort action, Bristol-Myers Squibb Co. v. [read post]
26 Mar 2020, 5:56 pm
The March 17 opinion answered several certified questions of Delaware law posed by the United States Court of Appeal for the Third Circuit to help it decide whether to uphold the dismissal of an amended federal qui tam complaint against Sanofi, Bristol-Meyers Squibb Co. and Aventis, Inc. under the False Claims Act 31 U.S.C. [read post]
6 Jan 2020, 3:13 pm
” (Bristol- Myers Squibb Co. v. [read post]
4 Oct 2019, 10:55 am
Noting that the First Circuit has not addressed the question, the court described two divergent approaches taken by district courts around the country on the personal jurisdiction issue: some courts, with which the Chavira court agreed, have ruled that the Supreme Court’s decision in Bristol-Myers Squibb Co. v. [read post]
13 Sep 2018, 6:00 am
While the opinion carefully reviews a string of such cases ending with Bristol-Meyers Squibb Co. v. [read post]
27 Jun 2018, 1:16 am
Additionally the court asks whether the principles in the cases Bristol-Meyers Squibb and Boehringer Ingelheim apply without restrictions to parallel imports of medical devices.When it comes to repackaging of goods, the Court emphasised that any repackaging done by a third party without the proprietor's consent could create a risk in terms of the guarantee of origin of the goods. [read post]
27 Jun 2018, 1:16 am
Additionally the court asks whether the principles in the cases Bristol-Meyers Squibb and Boehringer Ingelheim apply without restrictions to parallel imports of medical devices.When it comes to repackaging of goods, the Court emphasised that any repackaging done by a third party without the proprietor's consent could create a risk in terms of the guarantee of origin of the goods. [read post]
20 Jul 2017, 7:44 am
Onglyza was co-developed by Bristol-Meyers Squibb and AstraZeneca and is a DPP-4 inhibitor. [read post]
25 Jun 2017, 10:42 pm
” Bristol-Meyers Squibb Co. v. [read post]
12 Apr 2016, 10:57 am
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Mar 2016, 8:01 am
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
